Randomized double blind phase 3b trial to evaluate the safety and efficacy of 2 treatment regimens of aztreonam 75 mg powder and solvent for nebulizer solution azetronam for inhalation solution (ALZI)
This study is evaluating an experimental drug in patients with cystic fibrosis and new onset respiratory tract Pseudomonas Aeruginosa infection.
Those eligible to participate in this study include:
Interactive Campus Map
2500 North State Street
Jackson, MS 39216
General Information: 601-984-1000
Patient Appointments: 888-815-2005